Covered recipient · General Payments record
JOHN T BARBAGIOVANNI
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$4,447.10
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $497.93 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $254.51 | 16 |
| Madrigal Pharmaceuticals | $58.51 | 1 |
| Phathom Pharmaceuticals, Inc. | $44.30 | 2 |
| Janssen Biotech, Inc. | $30.48 | 2 |
| Gilead Sciences, Inc. | $24.50 | 1 |
| Ardelyx, Inc. | $24.44 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $16.66 | 1 |
| QOL Medical, LLC | $15.80 | 1 |
| Lilly USA, LLC | $14.54 | 1 |
| PFIZER INC. | $14.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.78 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277739 | CMS |
| ABBVIE INC. | $21.40 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277741 | CMS |
| ABBVIE INC. | $24.88 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277743 | CMS |
| ABBVIE INC. | $20.82 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277745 | CMS |
| ABBVIE INC. | $19.47 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277747 | CMS |
| ABBVIE INC. | $6.47 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277749 | CMS |
| ABBVIE INC. | $22.73 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277751 | CMS |
| ABBVIE INC. | $21.56 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277753 | CMS |
| ABBVIE INC. | $20.93 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277755 | CMS |
| ABBVIE INC. | $15.62 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277757 | CMS |
| ABBVIE INC. | $18.94 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277759 | CMS |
| ABBVIE INC. | $0.42 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277761 | CMS |
| ABBVIE INC. | $0.19 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277763 | CMS |
| ABBVIE INC. | $13.08 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277765 | CMS |
| ABBVIE INC. | $10.71 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277767 | CMS |
| ABBVIE INC. | $20.51 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277769 | CMS |
| Ardelyx, Inc. | $24.44 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146670527 | CMS |
| Gilead Sciences, Inc. | $24.50 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133640738 | CMS |
| Intercept Pharmaceuticals, Inc. | $16.66 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113635458 | CMS |
| Janssen Biotech, Inc. | $14.95 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078603788 | CMS |
| Janssen Biotech, Inc. | $15.53 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078603551 | CMS |
| Lilly USA, LLC | $14.54 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135072419 | CMS |
| Madrigal Pharmaceuticals | $58.51 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144161201 | CMS |
| PFIZER INC. | $14.19 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131942255 | CMS |
| Phathom Pharmaceuticals, Inc. | $20.30 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151038430 | CMS |
| Phathom Pharmaceuticals, Inc. | $24.00 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151038432 | CMS |
| QOL Medical, LLC | $15.80 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147730508 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.